Activity of liver microsomal enzymes during the chronic phase of murine schistosomiasis

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 5, 2007, Pages 657-662

  Conte, F P ^a   Fidalgo Neto, A A ^a   Manhaes Rocha D A ^a   Paumgartten, F J R ^a   De Oliveira, Ana C A X ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cytochrome P 450; Granuloma; Liver microsomes; Monooxygenases; Pharmacokinetics; Schistosoma mansoni

Indexed keywords

4 NITROPHENOL HYDROXYLASE; BENZYLOXYRESORUFIN DEALKYLASE; COUMARIN 7 HYDROXYLASE; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2E1; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; LIVER ENZYME; METHOXYRESORUFIN DEALKYLASE; OXYGENASE; PENTOXYRESORUFIN DEALKYLASE; UNCLASSIFIED DRUG; UNCLASSIFIED ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CERCARIA (TREMATODE LARVA); CONTROLLED STUDY; DBA 2 MOUSE; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; LIVER FIBROSIS; LIVER INJURY; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; PARASITIC LIVER DISEASE; PROTEIN CONTENT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SEX DIFFERENCE; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE;

MURINAE; MUS; SCHISTOSOMA MANSONI;

EID: 34248225836     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2006005000091     Document Type: Article

References (20)

1. Galtier P, Battaglia A, More J, Franc M. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat. J Pharm Pharmacol 1983; 35: 729-733.
2. Calleja C, Bigot K, Eeckhoutte C, Sibille P, Boulard C, Galtier P. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica. Int J Parasitol 2000; 30: 953-958.
3. Montero R, Gentile GJ, Frederick L, McMannis J, Murphy T, Silva G, et al. Induced expression of CYP2A5 in inflamed trematode-infested mouse liver. Mutagenesis 1999; 14: 217-220.
4. Kirby GM, Pelkonen P, Vatanasapt V, Camus AM, Wild CP, Lang MA. Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol Carcinog 1994; 11: 81-89.
5. Satarug S, Lang MA, Yongvanit P, Sithithaworn P, Mairiang E, Mairiang P, et al. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, Opisthorchiasis viverrini. Cancer Epidemiol Biomarkers Prev 1996; 5: 795-800.
6. Sheweita SA, Mangoura SA, el-Shemi AG. Different levels of Schistosoma mansoni infection induce changes in drug-metabolizing enzymes. J Helminthol 1998; 72: 71-77.
7. Manhaes-Rocha DA, Conte FP, Fidalgo-Neto AA, De-Oliveira AC, Ribeiro-Pinto LF, Paumgartten FJ. Alterations of hepatic microsomal enzymes in the early phase of murine schistosomiasis. Acta Trop 2005; 95: 58-66.
8. Cha YN, Edwards R. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice. J Pharmacol Exp Ther 1976; 199: 432-440.
9. Sheweita SA, Mubark J, Doenhofe MJ, Mostafa MH, Margison GP, O'Connor PJ, et al. Changes in the expression of cytochrome P450 isozymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice. J Helminthol 2002; 76: 71-78.
10. Cheever AW, Lenzi JA, Lenzi HL, Andrade ZA. Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 2002; 97: 917-940.
11. Fidalgo-Neto AA, De-Carvalho RR, De-Oliveira ACAX, Manhães-Rocha DA, Paumgartten FJR. Penetration and maturation of Schistosoma mansoni in suckling and adult Swiss Webster and DBA/2 mice. J Exp Anim Sci 2004; 43: 29-38.
12. Allis JW, Robinson BL. A kinetic assay for p-nitrophenol hydroxylase in rat liver microsomes. Anal Biochem 1994; 219: 49-52.
13. Cha YN, Byram JE, Heine HS, Bueding E. Effect of Schistosoma mansoni infection on hepatic drug-metabolizing capacity of athymic nude mice. Am J Trop Med Hyg 1980; 29: 234-238.
14. Cha YN, Heine HS, Bueding E. Effect of unisexual Schistosoma mansoni infections on hepatic drug metabolism of mice. Am J Trop Med Hyg 1980; 29: 227-233.
15. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci U S A 1993; 90: 11147-11151.
16. Morgan ET. Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 2001; 29: 207-212.
17. Gilmore WJ, Hartmann G, Piquette-Miller M, Marriott J, Kirby GM. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression. Toxicology 2003; 184: 211-226.
18. De-Oliveira AC, Da-Matta AC, Paumgartten FJ. Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver. Exp Parasitol 2006; 113: 256-261.
19. Brunet LR, Dunne DW, Pearce EJ. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 1998; 14: 422-427.
20. Kolodziejczyk L, Siemieniuk E, Skrzydlewska E. Antioxidant potential of rat liver in experimental infection with Fasciola hepatica. Parasitol Res 2005; 96: 367-372.